Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet ELTROMBOPAG SANDOZ 25mg film-coated tablets
- Product code:
- W71113001
- Quantity:
- 10
- Indicated for:
- thrombocytopenia
- Route of administration:
- oral
- Substance:
- eltrombopag (anticoagulant)
- ATC
- B02BX05 — Blood and blood forming organs | Vitamin k and other hemostatics | Other systemic hemostatics
Precautions:
Major drug interactions
This medicine may have important interactions with other medicines.
Additional monitoring
This medicine is subject to additional monitoring.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Bleeding risk
This medicine may increase the risk of bleeding.
Eltrombopag is a medication used to treat thrombocytopenia, a condition characterized by a low platelet count in the blood. It is particularly indicated for patients with chronic idiopathic thrombocytopenic purpura or other conditions affecting platelet production.
This medication works by stimulating thrombopoietin receptors in the bone marrow, leading to increased platelet production. It is taken orally, usually once daily, as directed by a doctor.
Eltrombopag is generally well-tolerated but may cause side effects such as nausea, fatigue, headaches, or elevated liver enzymes. In rare cases, there may be an increased risk of blood clots.
It is important to strictly follow your doctor's recommendations and undergo regular blood tests to monitor the treatment's effects. Do not discontinue the medication without consulting a specialist.
This medication works by stimulating thrombopoietin receptors in the bone marrow, leading to increased platelet production. It is taken orally, usually once daily, as directed by a doctor.
Eltrombopag is generally well-tolerated but may cause side effects such as nausea, fatigue, headaches, or elevated liver enzymes. In rare cases, there may be an increased risk of blood clots.
It is important to strictly follow your doctor's recommendations and undergo regular blood tests to monitor the treatment's effects. Do not discontinue the medication without consulting a specialist.
General data about ELTROMBOPAG SANDOZ 25mg
- Substance:
- eltrombopag
- Date of latest medicines list:
- 01-06-2025
- Product code:
- W71113001
- Concentration:
- 25mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 10
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for eltrombopag
- 12.5mg
- 25mg
- 50mg
- 75mg